Digital Health In Neurology Market (2026 - 2033)

Digital Health In Neurology Market Summary

The global digital health in neurology market size was valued at USD 48.5 billion in 2025 and is projected to grow from USD 59.4 billion in 2026 to USD 246.9 billion in 2033, at a CAGR of 22.6% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.0% in 2025. Increasing smartphone penetration, advancing healthcare IT infrastructure, improved internet connectivity, increasing prevalence of chronic diseases, rising healthcare expenditure, growing demand for remote patient monitoring services, and increasing accessibility of virtual care are driving the adoption of digital health technologies in neurology.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

The global healthcare sector has encountered numerous challenges during the pandemic. However, these circumstances accelerated the advancement of digital health technologies, especially in disease management, technology development, and frontline care delivery. Many countries have adopted remote monitoring platforms, telemedicine, and telehealth services to facilitate communication between physicians and patients. As a result, the digital health industry experienced significant revenue growth and is expected to continue growing profitably in the coming years, maintaining rapid expansion throughout the forecast period.

Government initiatives promoting global digitalization in healthcare are significantly driving market growth. For example, in January 2024, the European Commission awarded an EU-funded collaborative research infrastructure (RI) grant of approximately USD 41 million to EBRAINS, which will last until 2026. This funding will assist EBRAINS in developing tools and services, such as digital twin approaches, to support communities in brain medicine, neuroscience, and brain-inspired technologies.

The Internet of Things (IoT) has been widely adopted as a digital healthcare platform. With advanced wearable devices, reliable mobile connectivity, and efficient data backup enabled by integrated analytics, IoT has transformed the healthcare industry by facilitating a range of activities. These include efficient tracking of patients, staff, and inventories, managing chronic conditions, optimizing drug prescriptions, and ensuring the availability of essential medical equipment. For instance, in April 2025, Phantom Neuro announced the successful completion of a USD 19 million Series A funding round led by Ottobock to expedite the development and commercialization of its muscle–machine interface technology. This funding will support regulatory activities, product development, and clinical validation of Phantom X, an AI-powered neural interface designed to enable intuitive control of prosthetic limbs and robotic devices.

Smartphones have transformed from simple entertainment and communication devices into essential tools for fitness and health tracking. Health-related applications have made it easier to manage daily activities by offering convenient ways to monitor overall well-being. For example, some companies are developing applications to track sleep patterns. In July 2025, Apollo Neuroscience released Version 4.0 of its Apollo mobile application, which included a redesigned user interface, personalized content recommendations, improved SmartVibes integration, and better connectivity with wearables. These enhancements aim to strengthen the digital therapeutic experience for stress management and neurological well-being.

The burden of neurological conditions is rising globally, with neurological disorders representing one of the recurring causes of disability worldwide. According to the Alzheimer's Association's 2025 Alzheimer's Disease Facts and Figures report, an estimated 7.2 million Americans aged 65 years and older are living with Alzheimer's dementia. In addition, the prevalence of Alzheimer’s increases with an increase in age:

• Total: 7.2 million
• Age Group (65–74 years): 1.9 million (26%)
• Age Group (75–84 years): 3.4 million (48%)
• Age Group (85+ years): 1.9 million (26%)

Similarly, according to the World Health Organization estimates, there are approximately 55 million individuals across the globe suffering from dementia. The consequences are many individuals suffering from the conditions and substantial healthcare costs. According to the World Health Organization's Global Status Report on Neurology published in 2025, neurological conditions now affect more than 40% of the global population, representing over 3 billion people, and remain the leading cause of ill health and disability worldwide. Hence, several companies and research institutes are investing in clinical trials, including the application of digital technologies in neurology.

Analyst Perspective

The market is experiencing steady growth, fueled by increased awareness of neurological disorders, a rising demand for remote patient monitoring, and a growing interest in personalized healthcare solutions. Healthcare providers are increasingly integrating digital health technologies into the management of neurological conditions, as these technologies improve disease monitoring, enhance treatment adherence, and enable timely clinical interventions. The expanding use of wearable devices, artificial intelligence, telehealth platforms, and connected care solutions is further supporting market growth. As the demand for accessible, data-driven, and patient-centric neurological care continues to rise, companies that focus on technological innovation, clinical validation, and diversified applications will be well-positioned to capitalize on long-term growth opportunities.

Components Insights

In 2025, the services segment accounted for the largest share of market revenue. This growth can be attributed to the increasing demand for installation, maintenance, training, and other related services. Market players often provide these services as packaged solutions or as standalone offerings. For example, McKesson Corporation offers Intrafusion, a comprehensive infusion management program that includes outpatient infusion services designed to streamline operations within the neurology department.

The rising demand for advanced software solutions and platforms, such as Electronic Medical Records (EMRs) and Electronic Health Records (EHRs), along with the growing need for upgrades and training to effectively utilize these solutions, further contribute to the expansion of the services segment. Key players in the market offer a wide range of pre- and post-installation services, including project planning, training, implementation, and resource allocation and optimization.

The software segment is expected to achieve the fastest CAGR over the forecast period, driven by the rapid adoption of software systems among patients, providers, insurance payers, and healthcare facilities. Rising healthcare expenditures and a growing trend toward healthcare digitalization are also fueling growth in the software segment. For instance, in February 2026, Medtronic announced that it received U.S. FDA approval for the BrainSense Electrode Identifier (EI), a software enhancement for its Percept neurostimulator platform. This digital tool enables clinicians to accurately identify electrode contacts using brain signal recordings, thereby improving programming efficiency and personalized treatment for patients with Parkinson's disease, essential tremor, and other neurological disorders.

End Use Insights

In 2025, the patient segment dominated the market share, primarily due to the shift towards patient-centered care and the growing demand for individuals to manage their own health. Companies are transforming the healthcare industry by introducing virtual consultations and patient-care devices designed to restore mobility or monitor various health parameters. For instance, in March 2025, MicroTransponder announced positive real-world clinical outcomes for its FDA-approved Vivistim Paired VNS System. This system showcased sustained improvements in upper-extremity function among chronic stroke survivors who received vagus nerve stimulation in conjunction with rehabilitation therapy. These findings underscore the increasing adoption of digital neurostimulation technologies for stroke rehabilitation and neurological recovery.

The provider segment also accounted for a significant share of the end-use market, driven by increased adoption of innovative technologies such as digital therapeutics and telemedicine. Healthcare providers are increasingly using digital solutions to deliver personalized treatment plans, remote consultations, and evidence-based therapies that go beyond traditional care. By integrating digital tools, providers can deliver more personalized and accessible care, ultimately improving patient outcomes.

Regional Insights

North America dominated the market in 2025 with a revenue share of around 40.0%, owing to growing healthcare IT expenditure, availability of adequate digital infrastructure, technological advancements, the emergence of startups, favorable government initiatives, growing smartphone penetration, readiness in adopting advanced technological solutions, constant improvements in internet connectivity, and a rise in funding & investments. For instance, in April 2025, the American Academy of Neurology (AAN) hosted its 77th Annual Meeting in San Diego, California, bringing together thousands of neurologists, neuroscience professionals, and researchers from around the world. The meeting featured more than 3,200 scientific abstracts across 25 neurology specialties, showcasing the latest advances in neurological research, digital health technologies, artificial intelligence, and innovative approaches to diagnosing and treating neurological disorders. In addition, factors such as advancements in coverage networks, growing smartphone penetration, an aging population, and a significant rise in the prevalence of neurodegenerative diseases are driving the industry's growth.

To learn more about this report, Download Free Sample Report

U.S. Digital Health In Neurology Market Trends

The digital health in neurology market in the U.S. held the largest share in 2025. The growth is attributed to the increasing prevalence of neurodegenerative diseases, such as Parkinson’s disease, Alzheimer’s disease, Huntington’s Disease, and others. Furthermore, several market players undertake initiatives to promote applications of digital technology in the neurology sector. For instance, in February 2024, Linus Health published a study highlighting the positive results of its Digital Clock and Recall in detecting early-stage Alzheimer's.

Asia Pacific Digital Health In Neurology Market Trends

The digital health in neurology market in the Asia Pacific is estimated to experience the fastest growth rate during the forecast period. Increasing adoption of eHealth platforms and healthcare expenditure in the region is expected to drive the regional market's growth. Moreover, the rising burden of neurological diseases, the increasing demand for remote patient monitoring, and technological advancements in the field, driven by increased government healthcare spending, are expected to drive industry growth in the Asia Pacific region. The growing involvement of key market players and the emergence of niche entrepreneurial ventures in the Asia-Pacific region have boosted the adoption of digital apps and platforms. Some examples of startups in the Asia-Pacific healthcare sector include Wysa, CureApp, Mobio Interactive, Tuhoon, UrbanYogi, and Revery.

China digital health in neurology market is expected to experience exponential growth, attributed to technological advancements, growing business initiatives among market players, and the rising prevalence of neurological disorders. For instance, in March 2025, Shanghai-based BrainAurora Medical Technology received approval from China's National Medical Products Administration (NMPA) for an expanded indication for its digital cognitive assessment platform to evaluate cognitive impairment associated with neurological disorders. The approval strengthens the adoption of AI-enabled digital neurology solutions in China by supporting earlier diagnosis and digital assessment of neurological diseases.

Key Digital Health In Neurology Company Insights

The digital health in neurology industry features a range of global, regional, and local players, making it a competitive market. The world’s leading companies are using partnerships, collaborations, acquisitions, mergers, and agreements as strategies to withstand the intense competition and increase their market share. Players in the market actively pursue mergers, partnerships, and collaborations to develop new digital health solutions in neurology. Some of the key players in the digital health market for neurology include AdvancedMD Inc., Teladoc Health, Inc., Blackrock Neurotech, and Proteus Digital Health, Inc. In contrast, Aural Analytics, AppliedVR, Inc., and BehaVR Inc. are some of the emerging market players operating in the digital health market for neurology.

Key Digital Health In Neurology Companies

The following key companies have been profiled for this study on the digital health in neurology market:

• Neofect Co., Ltd.

• Teladoc Health, Inc.

• Proteus Digital Health, Inc.

• Akili, Inc.

• AppliedVR, Inc.

• Aural Analytics, Inc.

• BehaVR, Inc.

• Big Health Inc.

• Omada Health, Inc.

• Blackrock Neurotech

• AdvancedMD, Inc.

Recent Developments

• In June 2025, Rune Labs announced that its StrivePD Pro platform was selected by the Michael J. Fox Foundation for Parkinson’s Research to support digital biomarker collection and remote patient monitoring in Parkinson’s disease studies. The collaboration expanded the use of AI-enabled analytics and wearable-derived data to improve disease monitoring, clinical decision-making, and decentralized neurological research.
• In February 2025, Medtronic announced the U.S. commercial launch of BrainSense Adaptive Deep Brain Stimulation (aDBS) for Parkinson’s disease treatment. The technology automatically adjusts stimulation in real time based on patient brain signals, reflecting continued advancements in AI-enabled digital neurology and personalized neurostimulation systems. In February 2024, Aptar collaborated with Biogen to design digital health solutions to enhance patient care for neurological and other rare diseases.
• In February 2024, Aptar collaborated with Biogen to develop digital health solutions designed to improve patient care, treatment adherence, and disease management for neurological and rare diseases. The collaboration combined Aptar’s experience in digital therapeutics, connected health technologies, and patient engagement platforms with Biogen’s focus on neurological care to support more personalized and data-driven treatment approaches.

Global Digital Health In Neurology Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global digital health in neurology market report based on component, end use, and region:

• Component Outlook (Revenue, USD Million, 2021 - 2033)

  • Software

  • Hardware

  • Services

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Patients

  • Providers

  • Payers

  • Others

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Sweden

    • Denmark

    • Norway

  • Asia Pacific

    • China

    • India

    • Japan

    • Australia

    • South Korea

    • Singapore

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait